YAP in MAPK pathway targeted therapy resistance

Documenti analoghi

• RAS-MAPK in ALK targeted therapy resistance
  di: Hrustanovic, Gorjan, et al.
  Pubblicazione: (2015)
• The Hippo effector YAP regulates the response of cancer cells to MAPK pathway inhibitors
  di: Lin, Luping, et al.
  Pubblicazione: (2015)
• EGFR targeted therapy resistance: current status, challenges, and future outlook
  di: Bivona, Trever G.
  Pubblicazione: (2020)
• Adaptive stress signaling in targeted therapy resistance in cancer
  di: Pazarentzos, Evangelos, et al.
  Pubblicazione: (2015)
• The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies
  di: Lin, Luping, et al.
  Pubblicazione: (2015)